Cite

HARVARD Citation

    Hellfritzsch, M. et al. (2016). Inconsistencies in reporting of renal elimination among NOACs: the case of apixaban. Pharmacoepidemiology and drug safety. 25 (3), pp. 346-348. [Online]. 
  
Back to record